Cargando…
The NHE3 Inhibitor Tenapanor Prevents Intestinal Obstructions in CFTR-Deleted Mice
Mutations in the CFTR chloride channel result in intestinal obstructive episodes in cystic fibrosis (CF) patients and in CF animal models. In this study, we explored the possibility of reducing the frequency of obstructive episodes in cftr(−/−) mice through the oral application of a gut-selective NH...
Autores principales: | Tan, Xinjie, Kini, Archana, Römermann, Dorothee, Seidler, Ursula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456459/ https://www.ncbi.nlm.nih.gov/pubmed/36077390 http://dx.doi.org/10.3390/ijms23179993 |
Ejemplares similares
-
Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers
por: Rosenbaum, David P., et al.
Publicado: (2018) -
Loss of luminal carbonic anhydrase XIV results in decreased biliary bicarbonate output, liver fibrosis, and cholangiocyte proliferation in mice
por: Zhou, Zhenzhen, et al.
Publicado: (2022) -
Intestine-Specific NHE3 Deletion in Adulthood Causes Microbial Dysbiosis
por: Xue, Jianxiang, et al.
Publicado: (2022) -
Discovery of Tenapanor: A First-in-Class Minimally
Systemic Inhibitor of Intestinal Na(+)/H(+) Exchanger
Isoform 3
por: Jacobs, Jeffrey W., et al.
Publicado: (2022) -
Upregulation of antimicrobial peptide expression in slc26a3-/- mice with colonic dysbiosis and barrier defect
por: Kini, Archana, et al.
Publicado: (2022)